Ramkumar Mandalam
Directeur/Membre du Conseil chez CRYOPORT, INC.
Fortune : 576 009 $ au 31/05/2024
Postes actifs de Ramkumar Mandalam
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CRYOPORT, INC. | Directeur/Membre du Conseil | 16/06/2014 | - |
| Independent Dir/Board Member | 16/06/2014 | - | |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Directeur/Membre du Conseil | 20/10/2010 | - |
| Directeur Général | 01/01/2005 | - | |
| President | 01/01/2005 | - | |
Stempeutics Research Pvt. Ltd.
 Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Directeur/Membre du Conseil | - | - |
| Citra Bioconsulting, Inc. | Directeur Général | 01/01/2021 | - |
| Fondateur | 01/01/2021 | - |
Historique de carrière de Ramkumar Mandalam
Anciens postes connus de Ramkumar Mandalam
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VERICEL CORPORATION | Directeur Technique/Scientifique/R&D | 01/01/1994 | 01/01/2000 |
| Corporate Officer/Principal | 01/01/1994 | 01/01/2000 | |
| GERON CORPORATION | Corporate Officer/Principal | - | - |
Formation de Ramkumar Mandalam
| University of Michigan | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Inde | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
| Transportation | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GERON CORPORATION | Health Technology |
| VERICEL CORPORATION | Health Technology |
| CRYOPORT, INC. | Transportation |
| Entreprise privées | 3 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Stempeutics Research Pvt. Ltd.
Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Health Technology |
| Citra Bioconsulting, Inc. |
- Bourse
- Insiders
- Ramkumar Mandalam
- Expérience
